Central Coast Medical Oncology Corporation — Santa Maria, California

Central Coast Medical Oncology Corporation is a clinical research site located in Santa Maria, California, United States 93454.

Crixeo Clinical Trials Trust Score: 26/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Coast Medical Oncology Corporation has participated in 44 clinical trials with 2 currently active.

Therapeutic areas: Breast Cancer, Relapsed or Refractory Multiple Myeloma, Non-Small Cell Lung Cancer.

Sponsors: NSABP Foundation Inc, Novartis Pharmaceuticals, Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Santa Maria

Browse all research sites in California · View every site in Santa Maria

Sponsor Feasibility Report

Trust Score: 26/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Coast Medical Oncology Corporation?

Central Coast Medical Oncology Corporation has a Crixeo Trust Score of 26/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Coast Medical Oncology Corporation conducted?

Central Coast Medical Oncology Corporation has 44 clinical trials on record, with 2 currently active. Their work covers Breast Cancer, Relapsed or Refractory Multiple Myeloma, Non-Small Cell Lung Cancer.

Is Central Coast Medical Oncology Corporation accredited by Crixeo Clinical Trials?

Central Coast Medical Oncology Corporation has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Coast Medical Oncology Corporation?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.